(0.11%) 5 186.65 points
(0.05%) 38 870 points
(-0.05%) 16 340 points
(0.20%) $78.64
(0.59%) $2.21
(-0.38%) $2 322.40
(-0.40%) $27.50
(2.42%) $988.25
(0.17%) $0.930
(0.86%) $10.92
(0.43%) $0.799
(-0.05%) $91.30
3 days till quarter result
(bmo 2024-05-10)
Expected move: +/- 0.00%
50.00% $ 0.000600
Live Chart Being Loaded With Signals
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective...
Stats | |
---|---|
Volumen de hoy | 483 600 |
Volumen promedio | 504 869 |
Capitalización de mercado | 308 408 |
EPS | $0 ( 2024-04-12 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0600 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-12-30 | Ehrlich Leo | Sell | 11 307 527 | Class B Common Stock |
2021-10-10 | Harness Jane A. | Buy | 500 000 | Stock Option |
2020-09-11 | Harness Jane A. | Buy | 58 394 | Class A Common Stock |
2019-09-01 | Harness Jane A. | Buy | 58 394 | Class A Common Stock |
2020-09-11 | Harness Jane A. | Sell | 21 606 | Class A Common Stock |
INSIDER POWER |
---|
-100.00 |
Last 91 transactions |
Buy: 118 435 245 | Sell: 65 639 262 |
Innovation Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Innovation Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-373 000 (0.00 %) |
EPS: | $-0.00630 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-373 000 (0.00 %) |
EPS: | $-0.00630 |
FY | 2022 |
Ingresos: | $18 000.00 |
Beneficio Bruto: | $-364 000 (-2 022.22 %) |
EPS: | $-0.0142 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.0400 |
Financial Reports:
No articles found.
Innovation
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico